ArticleFrontiers in immunology2024

Efficacy analysis of rituximab in treating patients with primary membranous nephropathy dependent on calcineurin inhibitors.

Zhuo Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.